Total Bone Uptake in Management of Metastatic Carcinoma of the Prostate-Reference-Cited by-同舟云学术

Total Bone Uptake in Management of Metastatic Carcinoma of the Prostate

Published:1987-03 Issue:3 Volume:137 Page:444-448
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Dann Jeffrey¹,Castronovo Frank P.¹,McKusick Kenneth A.¹,Griffin Pamela P.¹,Strauss H. William¹,Prout George R.¹

Affiliation:

1. From the Urological Service and Department of Radiology, Massachusetts General Hospital, Department of Surgery, Harvard Medical School, Boston, Massachusetts

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference18 articles.

1. Bone scanning in prostatic cancer;Pollen;Urology,1981

2. On low acid phosphatase values of patients with known metastatic cancer of the prostate;London;Cancer Res.,1954

3. Comparative value of bone scintigraphy and radiography monitoring tumor response in systemi-cally treated prostatic carcinoma;Levenson;Radiology,1983

4. A simplified technique for quantifying 24-h whole body retention of 99mTc-labeled methylene diphosphonate;Castronovo;Int. J. Nucl. Med. Biol.,1985

5. The use of whole body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease;Fogelman;J. Nucl. Med.,1978

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Significance of Bone Metastasis Patterns in Patients with Prostate Cancer;UroOncology;2004-09

2. Is there a favorable subset of patients with prostate cancer who develop oligometastases?;International Journal of Radiation Oncology*Biology*Physics;2004-01

3. Quantitative evaluation of bone metastases in patients with advanced prostate cancer during systemic treatment;BJU International;2003-08-21

4. Percentage of the positive area of bone metastasis is an independent predictor of disease death in advanced prostate cancer;British Journal of Cancer;2003-01

5. Prognostic Significance of Extent of Disease in Bone in Patients With Androgen-Independent Prostate Cancer;Journal of Clinical Oncology;1999-03